Dr. Samantha Correia
Senior Research Scientist
Samantha brings with her 10 years of experience in molecular biology with a main focus in DNA design and optimisation, including 5 years in gene therapy research in industry. At ExEd Samantha plays a key role in developing our understanding of how DNA (transgene) design influences protein production.
Bio
Samantha completed her BSc at the University of Leeds specialising in Virology. She continued with a MRes & PhD at Imperial University continuing her focus on virology, with a PhD focused on Epstein Barr virus genetics under the supervision of Prof Paul Farrell.
Prior to joining ExEd’s, Samantha has spent 5 years within the gene therapy field focusing on AAV cassette & vector optimisation. She has worked on optimising AAV delivering liver-directed proteins & CNS-directed miRNAs. She has extensive knowledge on promoter design, transgene optimisation & AAV biology to improve therapeutic candidates & has been able to improve AAV mediated protein expression by 100-fold through AAV cassette modifications.
Prior to joining ExEd, Samantha held Senior Scientist roles in the gene therapy biotechs Freeline Therapeutics and AviadoBio.
Samantha brings with her 10 years of experience in molecular biology with a main focus in DNA design and optimisation, including 5 years in gene therapy research in industry. At ExEd Samantha plays a key role in developing our understanding of how DNA (transgene) design influences protein production.
Bio
Samantha completed her BSc at the University of Leeds specialising in Virology. She continued with a MRes & PhD at Imperial University continuing her focus on virology, with a PhD focused on Epstein Barr virus genetics under the supervision of Prof Paul Farrell.
Prior to joining ExEd’s, Samantha has spent 5 years within the gene therapy field focusing on AAV cassette & vector optimisation. She has worked on optimising AAV delivering liver-directed proteins & CNS-directed miRNAs. She has extensive knowledge on promoter design, transgene optimisation & AAV biology to improve therapeutic candidates & has been able to improve AAV mediated protein expression by 100-fold through AAV cassette modifications.
Prior to joining ExEd, Samantha held Senior Scientist roles in the gene therapy biotechs Freeline Therapeutics and AviadoBio.
Samantha brings with her 10 years of experience in molecular biology with a main focus in DNA design and optimisation, including 5 years in gene therapy research in industry. At ExEd Samantha plays a key role in developing our understanding of how DNA (transgene) design influences protein production.
Bio
Samantha completed her BSc at the University of Leeds specialising in Virology. She continued with a MRes & PhD at Imperial University continuing her focus on virology, with a PhD focused on Epstein Barr virus genetics under the supervision of Prof Paul Farrell.
Prior to joining ExEd’s, Samantha has spent 5 years within the gene therapy field focusing on AAV cassette & vector optimisation. She has worked on optimising AAV delivering liver-directed proteins & CNS-directed miRNAs. She has extensive knowledge on promoter design, transgene optimisation & AAV biology to improve therapeutic candidates & has been able to improve AAV mediated protein expression by 100-fold through AAV cassette modifications.
Prior to joining ExEd, Samantha held Senior Scientist roles in the gene therapy biotechs Freeline Therapeutics and AviadoBio.
→